Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading
Sector: Biotechnology · Market Cap: $1.2B · 0 insider purchases in the last 7 days
No open market insider purchases at Corvus Pharmaceuticals, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track CRVS on your watchlist.
Start for FreeAbout Corvus Pharmaceuticals, Inc. Insider Trading
1 insider at Corvus Pharmaceuticals, Inc. (CRVS) has purchased stock in the past 90 days, totaling $250K across 1 transaction (21,700 shares).
The most recent purchase was by Director Moore David Scott on June 11, 2026 — a $250K buy of 21,700 shares at $11.53, bringing their total holdings to 21,700 shares.
CRVS is in the Biotechnology sector within the Biotechnology industry with a market cap of $1.2B.
Track CRVS insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.